Genmab A/S ADR
(GMAB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GMAB | INCY | RVMD | ||
| Company | Genmab A/S ADR | Incyte Corp | Revolution Medicines Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 30.05 | 98.87 | 98.65 | ||
| High | 30.17 | 102.20 | 98.79 | ||
| Low | 29.47 | 97.90 | 97.12 | ||
| Latest | 29.59 | 100.75 | 97.33 | ||
| Change | -0.47 | +1.91 | -0.66 | ||
| % Change | -1.56% | +1.93% | -0.67% | ||
| Volume | 1,372,500 | 1,700,600 | 1,553,000 | ||
| 20-Day Average Volume | 1,777,770 | 1,952,990 | 3,127,315 | ||
| Previous Close | 30.06 | 98.84 | 97.99 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 32.27 | 103.01 | 103.76 | ||
| 20-Day Raw Stochastic | 2.30% | 28.62% | 15.10% | ||
| 20-Day Relative Strength | 39.56 | 48.06 | 52.04 | ||
| Weighted Alpha | +36.52 | +46.48 | +105.70 | ||
| Today's Opinion | 24% Buy | 64% Buy | 80% Buy | ||
| Previous Opinion | 40% Buy | 64% Buy | 80% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.46% since 02/05/26 | -1.96% since 02/05/26 | +1.23% since 02/05/26 | ||
| Low | 29.47 on 02/12/26 | 97.25 on 02/11/26 | 93.79 on 02/11/26 | ||
| High | 31.31 on 02/06/26 | 109.48 on 02/09/26 | 99.58 on 02/06/26 | ||
| 1-Month | |||||
| %Chg | -12.84% since 01/12/26 | -5.25% since 01/12/26 | -16.93% since 01/12/26 | ||
| Low | 29.47 on 02/12/26 | 97.25 on 02/11/26 | 92.50 on 01/26/26 | ||
| High | 35.43 on 01/14/26 | 109.48 on 02/09/26 | 124.49 on 01/16/26 | ||
| 3-Month | |||||
| %Chg | -2.89% since 11/12/25 | -6.94% since 11/12/25 | +47.85% since 11/12/25 | ||
| Low | 29.47 on 02/12/26 | 93.54 on 12/12/25 | 63.50 on 11/14/25 | ||
| High | 35.43 on 01/14/26 | 112.29 on 01/07/26 | 124.49 on 01/16/26 | ||
| 6-Month | |||||
| %Chg | +35.30% since 08/12/25 | +23.45% since 08/12/25 | +176.04% since 08/12/25 | ||
| Low | 22.18 on 08/13/25 | 81.09 on 09/25/25 | 34.88 on 08/13/25 | ||
| High | 35.43 on 01/14/26 | 112.29 on 01/07/26 | 124.49 on 01/16/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 19,310,062 | 19,404,562 | 18,943,428 | ||
| Shares Outstanding, K | 642,384 | 196,323 | 193,320 | ||
| Annual Sales | 3,121,270,000 | 4,241,220,000 | 0 | ||
| Annual Net Income | 1,137,380,000 | 32,610,000 | -600,090,000 | ||
| Last Quarter Sales | 1,022,000,000 | 1,365,980,000 | 0 | ||
| Last Quarter Net Income | 401,000,000 | 424,170,000 | -305,210,000 | ||
| 60-Month Beta | 0.90 | 0.82 | 1.01 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.65 on 11/06/25 | 1.80 on 02/10/26 | -1.61 on 11/05/25 | ||
| Latest Earnings Date | 02/17/26 | 05/05/26 | 02/25/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 14.78 | 17.28 | 0.00 | ||